Listed by the USPTO as JOHNSON, DANIELLE D
Tech Center 1600 • Art Units: 1611 1614 1616 1617 1655
This examiner grants 45% of resolved cases
JOHNSON, DANIELLE D works in USPTO Tech Center 1600 and Art Unit 1611. Across 737 resolved cases, the profile shows a 45.0% allowance rate and a median of 1481 days to allowance. Interview lift is 13.2%, indicating a limited association between interviews and changes in case outcomes.
The listed companies are BATTELLE MEMORIAL INSTITUTE, Medline Industries L.P., and Tohoku University. The associated firms are FITCH EVEN TABIN & FLANNERY, LLP, PA - BOZICEVIC FIELD & FRANCIS LLP, and BUCHANAN INGERSOLL & ROONEY PC. The substantial record and extended pendency support deliberate response planning and careful preservation of claim scope.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17721016 | WARMING CABINET AND METHOD OF DISINFECTING SKIN | Final Rejection | Medline Industries, LP |
| 18700428 | COMPOSITION | Non-Final OA | Syngenta Crop Protection AG |
| 16306972 | Compositions and Methods of Increasing Plant Yield and Improving Pest Resistance | Final Rejection | BASF Corporation |
| 18659445 | ANGIOGENESIS MATERIAL, BONE-REGENERATION-PROMOTING MATERIAL, METHOD FOR PRODUCING ANGIOGENESIS MATERIAL, AND METHOD FOR PRODUCING BONE-REGENERATION-PROMOTING MATERIAL | Non-Final OA | TOHOKU UNIVERSITY |
| 18688389 | NANOTECHNOLOGY FOR CHEMOTHERA0PY DRUG CAPTURE | Final Rejection | The Penn State Research Foundation |
| 18711671 | COMPOSITION FOR STABILIZING ACTIVE INGREDIENTS | Final Rejection | L'OREAL |
| 18273853 | Resin Composition and Member, Laminate, and Sustained Release Insect Repellent Preparation Containing Said Resin Composition | Final Rejection | SUMITOMO CHEMICAL COMPANY, LIMITED |
| 18730394 | Arthropod Control Compositions | Final Rejection | FIRMENICH SA |
| 19032744 | AQUEOUS COMPOSITIONS COMPRISING SOLUBILZED LIPO-CHITOOLIGOSACCHARIDES | Non-Final OA | NOVONESIS PLANT BIOSOLUTIONS A/S |
| 17794318 | Herbicide Combinations Comprising Glufosinate and Saflufenacil | Non-Final OA | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION |
| 17856029 | AGRICULTURAL COMPOSITIONS FOR IMPROVED CROP PRODUCTIVITY AND ENHANCED PHENOTYPES | Non-Final OA | Spogen Biotech Inc. |
| 17918826 | Anhydrous Azelaic Acid Topical Formulations | Non-Final OA | MF Beauty Partners LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy45.0% of resolved applications examined by Danielle D Johnson were allowed (737 resolved cases), compared with 35.0% across Art Unit 1611 over the last five years.
This examiner's interview lift is +13.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Danielle D Johnson took 1,481 days on average from filing to allowance.
Danielle D Johnson examines applications in Art Unit 1611 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
